Published on: August 02, 2024
The gene therapy market is at the forefront of the biotechnology and pharmaceutical sectors, pioneering advanced targeted therapies and genetic treatments for medical disorders. It encompasses a wide array of innovative products and technologies aimed at treating genetic diseases and acquired disorders. Gene therapies can target areas neurology, rare CNS disorders, and oncology, among others. Disease indications such as B-cell acute lymphoblastic leukemia and metachromatic leukodystrophy are addressed through gene therapy products in clinical development.
Gene therapy market size is estimated to grow between 2022 and 2027 accelerating at a CAGR of 19.91% during the forecast period. The growth of the market depends on factors such as the increase in special drug designations, the associated benefits, and the increasing prevalence of chronic diseases.
The gene therapy market is expanding rapidly, driven by advancements in genomics, molecular biology, and biotechnology. It is projected to grow significantly due to increasing investments from pharmaceutical and biotechnology companies, with a promising clinical pipeline and the commercialization of novel therapies.
Key trends in the gene therapy market include the development of viral vectors and hybrid vector systems for efficient gene delivery, as well as a notable rise in the use of CRISPR-Cas9 technology and genome sequencing to target therapeutic areas more precisely. Moreover, strategic acquisitions and partnerships among organizations are accelerating research and development efforts.
Drivers of the gene therapy market include the demand for innovative treatments for inherited genetic diseases such as hemophilia, sickle cell disease, and muscular dystrophy. The rise in CAR T-cell therapy and other immunotherapy approaches for cancer treatment also fuels market growth. Regulatory approvals and favorable reimbursement policies further support market expansion globally.
Challenges in the gene therapy market include high development costs, stringent quality standards, and complex supply chain requirements. Issues related to storage and transportation conditions, especially maintaining ultra-cold temperatures for biological products like gene therapies, pose logistical challenges. Adoption barriers in developing regions due to affordability and infrastructure limitations are also significant challenges.
North America is projected to account for 39% of the global market’s growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market. The US has become a lucrative country for investments in the North American gene therapy market. This is because of the funding provided by government departments such as the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) to small-scale industries and companies that are focusing on developing novel products. The increasing funds from government and private organizations will foster the development of gene therapies during the forecast period.
Technavio's gene therapy industry reports monitor the leading players in the global market along with their current and forecasted market share. Our analysis covers regional and global companies. Some of the top companies covered in our gene therapy market reports include:
In order to provide you with a comprehensive view of the gene therapy industry, our experts analyze the market from many different perspectives. Our reports help identify opportunities, risks, key competitors, and more, helping you make timely, informed decisions to optimize your position in the market.
Technavio reports insights include:
Develop a deeper understanding of the gene therapy market with Technavio’s comprehensive market research reports. We provide the latest information on key industry dynamics, including global and regional market forecasts, internal and external pressure points, the vendor landscape, and more.
Our in-depth knowledge of the gene therapy market is built on decades of experience and a global network of industry experts. We know the importance of having a strong foundation on which to base important decisions, and with over 500 analysts located around the world, we deliver actionable insights for every segment of the market.
Technavio’s market research reports provide an analysis of current trends and how they are affecting the market. We also identify market drivers and challenges to help you discover opportunities and avoid pitfalls.
Every Technavio report includes detailed segmentation insights, breaking down the market in terms of product type, geography, sales channels, and more. And if you’re looking for something a little more specific, our Custom Research Solutions can tailor any report to meet your unique needs.
We provide detailed profiles on the biggest competitors in the market, including data such as business divisions, product offerings, and news. Our reports also include an overview of the competitive landscape as a whole, including the risks and opportunities that it presents.
LinkedIn
Facebook 
Twitter
Email
Reddit
Tumblr
Quora
Pinterest
WhatsApp